ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Retrospective Cohort Study |
Article Title |
Trends in treatment and overall survival among patients with proximal esophageal cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Judith de Vos-Geelen, Sandra ME Geurts, Margreet van Putten, Liselot BJ Valkenburg-van Iersel, Heike I Grabsch, Nadia Haj Mohammad, Frank JP Hoebers, Chantal V Hoge, Paul M Jeene, Evelien JM de Jong, Hanneke WM van Laarhoven, Tom Rozema, Marije Slingerland, Vivianne CG Tjan-Heijnen, Grard AP Nieuwenhuijzen and Valery EPP Lemmens |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Judith de Vos-Geelen, MD, Doctor, Doctor, Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, P. Debyelaan 25, Maastricht 6202 AZ, Netherlands. judith.de.vos@mumc.nl |
Key Words |
Esophagus; Esophageal cancer; Proximal; Cervical; Upper thoracic; Trends |
Core Tip |
Proximal esophageal cancer is a rare disease, accounting for only 10% of all esophageal cancer cases. Limited data on treatment and survival in this rare tumor have been published, restricting patient counseling. The present investigation is the largest population-based cohort study evaluating trends in treatment and survival in proximal esophageal cancer. This study represents daily clinical practice, showing improvement in overall survival in patients with non-metastatic proximal esophageal cancer, with a shift to non-surgical treatment. |
Publish Date |
2019-12-20 10:20 |
Citation |
de Vos-Geelen J, Geurts SME, van Putten M, Valkenburg-van Iersel LBJ, Grabsch HI, Haj Mohammad N, Hoebers FJP, Hoge CV, Jeene PM, de Jong EJM, van Laarhoven HWM, Rozema T, Slingerland M, Tjan-Heijnen VCG, Nieuwenhuijzen GAP, Lemmens VEPP. Trends in treatment and overall survival among patients with proximal esophageal cancer. World J Gastroenterol 2019; 25(47): 6835-6846 |
URL |
https://www.wjgnet.com/1007-9327/full/v25/i47/6835.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v25.i47.6835 |